Dynamic contrast enhanced MRI in prostate cancer

Area of Science:

• Radiology and Imaging
• Oncology
• Urology

Background:

• Angiogenesis is crucial in benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), and prostate cancer growth and metastasis.
• Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with gadolinium chelates offers non-invasive assessment of tissue vascularity.

Purpose of the Study:

• To review two dynamic MRI techniques (T2*-weighted and T1-weighted) for prostate gland evaluation.
• To discuss the biological basis, data acquisition, analysis, limitations, and validation of these DCE-MRI methods.
• To outline established clinical roles and limitations of T1-weighted DCE-MRI in prostate cancer detection and staging.

Main Methods:

• Discussion of T2*-weighted (susceptibility-based) and T1-weighted (relaxivity-enhanced) DCE-MRI techniques.
• Review of data acquisition, analysis methodologies, and biological underpinnings.
• Examination of technical limitations and validation studies.

Main Results:

• DCE-MRI provides insights into tissue perfusion, microvessel permeability, and extracellular leakage space.
• T1-weighted DCE-MRI has established roles in lesion detection, localization, tumor staging, and recurrence detection.
• Limitations exist in differentiating prostatitis from cancer and benign prostatic hyperplasia from central gland tumors.

Conclusions:

• DCE-MRI techniques, particularly T1-weighted imaging, are valuable non-invasive tools for evaluating prostate vascularity.
• Further refinement is needed to overcome limitations in characterizing prostate lesions and distinguishing between benign and malignant conditions.
• DCE-MRI holds significant potential for improving prostate cancer diagnosis and management.